Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery.

Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D.

Am J Clin Oncol. 2015 Apr;38(2):184-8. doi: 10.1097/COC.0b013e31828aadc9.

PMID:
23563214
2.

Risk factors for significant wound complications following wide resection of extremity soft tissue sarcomas.

Schwartz A, Rebecca A, Smith A, Casey W, Ashman J, Gunderson L, Curtis K, Chang YH, Beauchamp C.

Clin Orthop Relat Res. 2013 Nov;471(11):3612-7. doi: 10.1007/s11999-013-3130-4. Epub 2013 Jun 28.

3.

Major wound complication risk factors following soft tissue sarcoma resection.

Moore J, Isler M, Barry J, Mottard S.

Eur J Surg Oncol. 2014 Dec;40(12):1671-6. doi: 10.1016/j.ejso.2014.10.045. Epub 2014 Oct 18.

PMID:
25456440
4.

Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.

Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D.

Radiat Oncol. 2013 Mar 14;8:60. doi: 10.1186/1748-717X-8-60.

5.
6.

Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas.

Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, Yasko AW, Benjamin RS, Pisters PW.

Cancer. 2006 Nov 15;107(10):2455-61.

7.

Surgery with vascular reconstruction for soft-tissue sarcomas in the inguinal region: oncologic and functional outcomes.

Emori M, Hamada K, Omori S, Joyama S, Tomita Y, Hashimoto N, Takami H, Naka N, Yoshikawa H, Araki N.

Ann Vasc Surg. 2012 Jul;26(5):693-9. doi: 10.1016/j.avsg.2011.12.003.

PMID:
22664282
8.

Clinical outcome of limb-salvage surgery after wide resection of sarcoma and femoral vessel reconstruction.

Muramatsu K, Ihara K, Miyoshi T, Yoshida K, Taguchi T.

Ann Vasc Surg. 2011 Nov;25(8):1070-7. doi: 10.1016/j.avsg.2011.05.009. Epub 2011 Aug 10.

PMID:
21831587
9.

Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.

Alektiar KM, Brennan MF, Singer S.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):202-8.

PMID:
16111590
10.

Concomitant arterial and venous reconstruction with resection of lower extremity sarcomas.

Baxter BT, Mahoney C, Johnson PJ, Selmer KM, Pipinos II, Rose J, Neff JR.

Ann Vasc Surg. 2007 May;21(3):272-9.

PMID:
17484959
11.

[Locally advanced soft-tissue sarcomas. An innovating triad to avoid amputation: isolated limb perfusion, TNFalpha, and free microsurgical flap].

Germain MA, Bonvalot S, Rimareix F, Missana CM.

Bull Acad Natl Med. 2010 Jan;194(1):51-65; discussion 65-7. French.

PMID:
20669559
12.

Results of limb-sparing surgery with vascular replacement for soft tissue sarcoma in the lower extremity.

Schwarzbach MH, Hormann Y, Hinz U, Bernd L, Willeke F, Mechtersheimer G, Böckler D, Schumacher H, Herfarth C, Büchler MW, Allenberg JR.

J Vasc Surg. 2005 Jul;42(1):88-97.

13.

Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma.

Olieman AF, Pras E, van Ginkel RJ, Molenaar WM, Schraffordt Koops H, Hoekstra HJ.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):807-14.

PMID:
9531364
14.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569-77.

PMID:
10348286
15.

The surgical and functional outcome of limb-salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity.

Ghert MA, Davis AM, Griffin AM, Alyami AH, White L, Kandel RA, Ferguson P, O'Sullivan B, Catton CN, Lindsay T, Rubin B, Bell RS, Wunder JS.

Ann Surg Oncol. 2005 Dec;12(12):1102-10. Epub 2005 Nov 1.

PMID:
16252136
16.

Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?

Levy A, Bonvalot S, Bellefqih S, Vilcot L, Rimareix F, Terrier P, Belemsagha D, Cascales A, Domont J, Mir O, Honoré C, Le Cesne A, Le Péchoux C.

Eur J Surg Oncol. 2014 Dec;40(12):1648-54. doi: 10.1016/j.ejso.2014.06.014. Epub 2014 Jul 25.

PMID:
25130960
17.

Assessment of multimodality therapy use for extremity sarcoma in the United States.

Sherman KL, Wayne JD, Chung J, Agulnik M, Attar S, Hayes JP, Laskin WB, Peabody TD, Bentrem DJ, Pollock RE, Bilimoria KY.

J Surg Oncol. 2014 Apr;109(5):395-404. doi: 10.1002/jso.23520. Epub 2013 Dec 20.

PMID:
24375444
18.

Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins.

Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG, Coia LR.

Cancer. 1993 Aug 15;72(4):1230-8.

19.

The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity.

Dagan R, Indelicato DJ, McGee L, Morris CG, Kirwan JM, Knapik J, Reith J, Scarborough MT, Gibbs CP, Marcus RB Jr, Zlotecki RA.

Cancer. 2012 Jun 15;118(12):3199-207. doi: 10.1002/cncr.26489. Epub 2011 Oct 21.

20.

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.

Edmonson JH, Petersen IA, Shives TC, Mahoney MR, Rock MG, Haddock MG, Sim FH, Maples WJ, O'Connor MI, Gunderson LL, Foo ML, Pritchard DJ, Buckner JC, Stafford SL.

Cancer. 2002 Feb 1;94(3):786-92.

Supplemental Content

Support Center